行情

ISR

ISR

ISORAY
AMEX
0.3658
+0.0268
+7.91%
盘后: 0.3500 -0.0158 -4.32% 19:53 10/05 EDT
开盘
0.3500
昨收
0.3390
最高
0.3750
最低
0.3300
成交量
89.69万
成交额
0
52周最高
0.6900
52周最低
0.1922
市值
5,198.48万
市盈率(TTM)
-8.2948
分时
5日
1月
3月
1年
5年
Isoray 获得 Viewpoint 分子靶向;股价下跌
Isoray 获得 Viewpoint 分子靶向;股价下跌
MT Newswires · 6天前
-- 收益快讯 (ISR) ISORAY 公布第四季度收入 250 万美元
-- 收益快讯 (ISR) ISORAY 公布第四季度收入 250 万美元
MT Newswires · 09/28 16:07
-- 收益快讯 (ISR) ISORAY 公布第四季度亏损 $-0.01
-- 收益快讯 (ISR) ISORAY 公布第四季度亏损 $-0.01
MT Newswires · 09/28 16:06
ISR 简况
Isoray, Inc. is a medical technology company. The Company, through its subsidiary, Isoray Medical, Inc., develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. The Company is engaged in production and sale of Cesium-131 brachytherapy seeds. Brachytherapy seeds are small devices that deliver a personalized targeted therapeutic dose of radiation used in an interstitial radiation procedure. The brachytherapy procedure places radioactive seeds as close as possible to (in or near) the cancerous tumor. The Cesium-131 includes radioisotope in the treatment of all malignant tumors, such as prostate cancer, brain cancer, colorectal cancer, gynecological cancer, lung cancer, ocular melanoma and pancreatic cancer. The Company’s Cesium-131 is classified as a Class II device.

微牛提供IsoRay, Inc.(AMEX-ISR)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的ISR股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易ISR股票基本功能。